This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (64)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Nutritional and Metabolic Disorders, Other  • Review  • Diabetes Mellitus  • Alert me on articles by topic  Social Bookmarking   What's this?

John E. Gerich, MD

Arch Intern Med. 2003;163:1306-1316.

It is well established that strict glycemic control (hemoglobin A_1c <7.0%) can prevent the microvascular complications of diabetes mellitus. Recent studies indicate that elevated plasma glucose concentrations are an independent and clinically significant risk factor for cardiovascular disease in nondiabetic and diabetic individuals. Thus, isolated postprandial hyperglycemia (2-hour postprandial glucose level >140 mg/dL [>7.8 mmol/L]) in the face of normal fasting plasma glucose (<110 mg/dL [<6.1 mmol/L]) and normal hemoglobin A_1c (<6.1%) values is associated with a 2-fold increased risk of death from cardiovascular disease. These observations imply that more strict glycemic control is required to prevent macrovascular disease than microvascular disease. This review summarizes epidemiologic and experimental studies linking postprandial hyperglycemia to cardiovascular disease and therapeutic approaches available and in development to treat this disorder.

From the Department of Medicine, University of Rochester Medical Center, Rochester, NY. Dr Gerich has served as consultant to or on advisory boards or speaker's bureaus for Novartis, Novo Nordisk, GlaxoSmithKline, Aventis, Bristol-Myers Squibb, Pfizer, and Emisphere Pharmaceuticals.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: Does proving this relationship really matter? Yes
Davidson and Parkin
Diabetes Care 2009;32:S331-S333.
FULL TEXT  

DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results: Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes
Buse et al.
Diabetes Care 2009;32:1007-1013.
ABSTRACT | FULL TEXT  

HIV-1 Protease Inhibitor Induced Oxidative Stress Suppresses Glucose Stimulated Insulin Release: Protection with Thymoquinone
Chandra et al.
Exp. Biol. Med. 2009;234:442-453.
ABSTRACT | FULL TEXT  

Impaired Hyperglycemia-Induced Delay in Gastric Emptying in Patients With Type 1 Diabetes Deficient for Islet Amyloid Polypeptide
Woerle et al.
Diabetes Care 2008;31:2325-2331.
ABSTRACT | FULL TEXT  

Insulin Analogs: Impact on Treatment Success, Satisfaction, Quality of Life, and Adherence
Hartman
Clin Med Res 2008;6:54-67.
ABSTRACT | FULL TEXT  

Post-Meal Glucose Peaks at Home Associate with Carotid Intima-Media Thickness in Type 2 Diabetes
Esposito et al.
J. Clin. Endocrinol. Metab. 2008;93:1345-1350.
ABSTRACT | FULL TEXT  

Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans
Woerle et al.
Am. J. Physiol. Endocrinol. Metab. 2008;294:E103-E109.
ABSTRACT | FULL TEXT  

Assessing Glycemic Control With Self-monitoring of Blood Glucose and Hemoglobin A1c Measurements
Dailey
Mayo Clin Proc. 2007;82:229-236.
ABSTRACT | FULL TEXT  

Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes Study
Cavalot et al.
J. Clin. Endocrinol. Metab. 2006;91:813-819.
ABSTRACT | FULL TEXT  

Incretin-based therapies: a clinical need filled by unique metabolic effects.
Drucker
The Diabetes Educator 2006;32:65S-71S.
FULL TEXT  

Effects of Different Insulin Regimes on Postprandial Myocardial Perfusion Defects in Type 2 Diabetic Patients
Scognamiglio et al.
Diabetes Care 2006;29:95-100.
ABSTRACT | FULL TEXT  

Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes
Woerle et al.
Am. J. Physiol. Endocrinol. Metab. 2006;290:E67-E77.
ABSTRACT | FULL TEXT  

Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects
Chaikomin et al.
Am. J. Physiol. Endocrinol. Metab. 2005;289:E504-E507.
ABSTRACT | FULL TEXT  

Abnormal Glucose Homeostasis and Pancreatic Islet Function in Mice with Inactivation of the Fem1b Gene
Lu et al.
Mol. Cell. Biol. 2005;25:6570-6577.
ABSTRACT | FULL TEXT  

Postprandial Myocardial Perfusion in Healthy Subjects and in Type 2 Diabetic Patients
Scognamiglio et al.
Circulation 2005;112:179-184.
ABSTRACT | FULL TEXT  

Is Nondiabetic Hyperglycemia a Risk Factor for Cardiovascular Disease?: A Meta-analysis of Prospective Studies
Levitan et al.
Arch Intern Med 2004;164:2147-2155.
ABSTRACT | FULL TEXT  

Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
Selvin et al.
ANN INTERN MED 2004;141:421-431.
ABSTRACT | FULL TEXT